BRIEF COMMUNICATION inTroducTion
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that primarily affects the synovial membranes of diarthrodial joints (1) . As a result of the breakdown of self-tolerance, autoantibodies produced during the initiation phase are deposited into the synovial tissue. During the effector phase, these autoantibodies orchestrate diverse innate immune cells such as mast cells, neutrophils, and synovial fibroblasts to trigger an inflammatory response, leading to progressive destruction of cartilage and bone (2) . These pathogenic processes are mirrored relatively well in the K/BxN mouse model. K/BxN mice spontaneously develop severe arthritis because of KRN transgenic T cells that specifically recognize a self-peptide derived from glucose-6-phosphate isomerase (GPI) in the context of MHC I-A g7 and anti-GPI autoantibodies (3) . Passive transfer of K/BxN serum containing anti-GPI autoantibodies to normal mice can bypass the initiation phase and directly execute effector functioning (4) . Therefore, a K/BxN serum transfer model allows for studies that focus specifically on the effector phase, driven mainly by innate immune cells, of inflammatory arthritis.
Neutrophils are abundant in the synovial tissue of RA patients and indispensable for the development of K/BxN serum-induced arthritis (5, 6 (8, 9) . In agreement with this, IL-17-deficient mice were found refractory to collagen-induced arthritis (CIA), indicating that IL-17 was essential in this model (10) . However, the sources and actions of IL-17 are not fully understood. For example, although Th17 cells and γd T cells are the main sources of IL-17 in the context of CIA, only Th17 cells, not γd T cells, induce arthritic bone destruction (11) . Moreover, IL-17-producing γd T cells evident in the CIA model are not present in SKG mice and RA patients (12) . In the K/BxN model, IL-17 is specifically required for the generation of anti-GPI autoantibodies (13) . However, it is not clear whether IL-17 is also required for the effector phase, since previous studies using the K/BxN serum-induced arthritis model have provided conflicting results (13, 14) .
In this study, we evaluated whether IL-17 is essential for the effector phase of inflammatory arthritis in the K/BxN serum transfer model. Moreover, we identified a novel cell population in the affected synovium that produced IL-17 in response to IL-23 or immune complexes.
maTerials and meThods mice

IL-17
-/-congenic C57BL/6 mice (hereafter referred to as IL-17 -/-mice) originally provided by Dr. Iwakura from Tokyo University were bred and maintained under specific pathogen-free conditions in accredited animal facilities at Hanyang University. C57BL/6 mice were purchased from Orient Bio. K/BxN mice were obtained by crossing KRN TCR transgenic mice on a C57BL/6 background (K/B) with NOD mice (15) . The study protocol was approved by the Institutional Animal Care and Use Committee of Hanyang University. All animal experiments were carried out in accordance with the committee guidelines and regulations.
establishment of K/bxn serum-induced arthritis Serum was collected from 8~12-week-old arthritic K/BxN mice. Wild-type (WT) and IL-17 -/-mice at 7 weeks of age were injected intraperitoneally with K/BxN serum (150 ml/ mouse). Arthritic signs were evaluated in a blinded manner, and disease severity was assessed using a previously described scoring system (15) . Ankle thickness of both hind paws was measured axially across the malleoli using a caliper. Hind paws were removed on day 12 after serum transfer, fixed, and decalcified in 5.5% EDTA in phosphatebuffered formalin. The specimens were embedded in paraffin, sectioned, and stained with H&E.
immunohistochemistry Hind paw tissues were fixed, embedded in paraffin, and sectioned at 7 mm in thickness. Standard immunohistochemical methods were then applied. Goat rabbit anti-mouse IL-17 Ab (eBioscience, San Diego, CA, USA) was used at the appropriate dilution. The sections were incubated with secondary Ab and exposed to avidinbiotin-peroxidase complexes and 3.3′-diminobenzidine (all from Vector Laboratories, Burlingame, CA, USA), followed by counterstaining with 1% methyl green solution.
synovial cell extraction and culture To prepare single cell suspensions from synovial cells of the mice, the synovial tissues around ankle joints were collected, sliced into small pieces, digested with 50 mg/ ml Liberase (Roche, Switzerland) at 37 o C for 40 min, and then filtered through cell strainers with a 70-mm pore size. The synovial cells were cultured in RPMI 1640 (Welgene, Gyeongsangbuk-do, South Korea) medium containing 10% FBS (Gibco, Detroit, MI, USA) in the presence or absence of 10 ng/ml IL-23 (BD Biosciences, San Jose, CA, USA) or immune complexes for 48 h. Immune complexes were prepared as described previously (16) . The cells were stimulated with a mixture of 40 ng/ml phorbol myristate acetate (PMA) (Sigma-Aldrich, St. Louis, MO, USA), 1 mg/ml ionomycin (Sigma-Aldrich), and Golgi-Stop (BD Biosciences) for the last 5 h of incubation to detect IL-17 expression by FACS. facs IL-17 expression by synovial cells was detected by FACS as previously described (17) . mAbs to mouse IL-17, Sca1, Thy1, CD11b, CD11c, Gr-1, NK1.1, and c-Kit were purchased from eBioscience, and mAbs to mouse CD4 and γd TCR were obtained from BD Biosciences.
rT-pcr RNA was purified from synovial cells using TRIzol (Invitrogen, Carlsbad, CA, USA) and assayed by RT-PCR as described previously (18) . The following primer sequences were used: IL-17, 5′-TCC AGA AGG CCC TCA GAC TA-3′ and 5′-AGC ATC TTC TCG ACC CTG AA-3′; IL-23, 5′-ATC CAG TGT GAA GAT GGT TG-3′ and 5'-GGA GTT GGC TGA GTC CTA GT-3′; b2 microglobulin (b2M), 5′-TGA CCAGCT TGT ATG CTA TC-3′ and 5′-CAG TGT GAG CCA GGA TAT AG-3′.
statistical analysis Data are presented as means±SEMs. Differences between groups were evaluated by unpaired Student's t-test. p values are indicated when differences between two groups were statistically significant (<0.05).
resulTs and discussion il-17-deficient mice are completely refractory to K/bxn serum-induced arthritis Autoantibodies abundant in K/BxN serum can induce arthritis in normal mice by initiating innate inflammatory responses in joints (4) . To determine the role of IL-17 in the innate effector phase of arthritis, we assessed the susceptibility of IL-17-deficient mice to K/BxN seruminduced arthritis. Whereas all WT mice developed severe arthritis, evident in ankle thicknesses and arthritic indices, in response to the serum, none of the IL-17 -/-mice showed any symptoms of arthritis (Fig. 1A) . Accordingly, severe leukocyte infiltration and bone invasion were observed in the hind-paw joints of serum-recipient WT mice, whereas the joint architecture of IL-17 -/-mice was intact compared to that of untreated mice (Fig. 1B) . IL-17-expressing cells were detected in the hind-paw synovial tissue of serum-recipient WT mice, but not in that of the serum-recipient IL-17 -/-mice (Fig. 1C) . In addition, IL-17 transcripts were more abundant in the synovial tissue of WT mice after serum transfer, but were undetectable in the tissue from IL-17 -/-mice, as expected (Fig. 1D) . IL-23 transcripts were similarly increased in both strains of mice in response to serum transfer. (Fig. 2A) . The IL-17-producing cells were identified in a fraction of Thy1 -/-mice, in response to serum transfer (Fig. 2C) . Therefore, these results suggest that IL-17 was produced by cells resident in the synovial tissue, rather than by cell infiltrates in response to arthritogenic stimulation, and these cells retained a phenotype distinct from all other lineages known to express IL-17 in the synovium. int synovial cells (Fig.  3A) .
Because autoantibodies present in K/BxN serum were the major arthritogenic factor, we evaluated whether autoantibody-containing immune complexes could 
Sca1
+ phenotype and responsiveness to IL-23 with IL-17-producing innate lymphoid cells identified in inflamed intestines.
Although previous studies have identified diverse populations of innate lymphoid cells, mostly residing in barrier tissues such as the skin, intestine, and lungs (23) , there have been no reports of these cells residing in synovial tissues. Here, we provide evidence of IL-17-producing synovium-resident cells. We also revealed that these cells are responsive to immune complexes and IL- 
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